295 related articles for article (PubMed ID: 30859363)
1. Combined choline and DHA supplementation: a randomized controlled trial.
Bernhard W; Böckmann K; Maas C; Mathes M; Hövelmann J; Shunova A; Hund V; Schleicher E; Poets CF; Franz AR
Eur J Nutr; 2020 Mar; 59(2):729-739. PubMed ID: 30859363
[TBL] [Abstract][Full Text] [Related]
2. Choline supplementation for preterm infants: metabolism of four Deuterium-labeled choline compounds.
Böckmann KA; Bernhard W; Minarski M; Shunova A; Wiechers C; Poets CF; Franz AR
Eur J Nutr; 2023 Apr; 62(3):1195-1205. PubMed ID: 36460779
[TBL] [Abstract][Full Text] [Related]
3. Prenatal choline supplementation improves biomarkers of maternal docosahexaenoic acid (DHA) status among pregnant participants consuming supplemental DHA: a randomized controlled trial.
Klatt KC; McDougall MQ; Malysheva OV; Taesuwan S; Loinard-González AAP; Nevins JEH; Beckman K; Bhawal R; Anderson E; Zhang S; Bender E; Jackson KH; King DJ; Dyer RA; Devapatla S; Vidavalur R; Brenna JT; Caudill MA
Am J Clin Nutr; 2022 Sep; 116(3):820-832. PubMed ID: 35575618
[TBL] [Abstract][Full Text] [Related]
4. Plasma phospholipids indicate impaired fatty acid homeostasis in preterm infants.
Bernhard W; Raith M; Koch V; Kunze R; Maas C; Abele H; Poets CF; Franz AR
Eur J Nutr; 2014 Oct; 53(7):1533-47. PubMed ID: 24464176
[TBL] [Abstract][Full Text] [Related]
5. Choline and polyunsaturated fatty acids in preterm infants' maternal milk.
Maas C; Franz AR; Shunova A; Mathes M; Bleeker C; Poets CF; Schleicher E; Bernhard W
Eur J Nutr; 2017 Jun; 56(4):1733-1742. PubMed ID: 27164830
[TBL] [Abstract][Full Text] [Related]
6. Postnatal adaptations of phosphatidylcholine metabolism in extremely preterm infants: implications for choline and PUFA metabolism.
Goss KCW; Goss VM; Townsend JP; Koster G; Clark HW; Postle AD
Am J Clin Nutr; 2020 Dec; 112(6):1438-1447. PubMed ID: 32778895
[TBL] [Abstract][Full Text] [Related]
7. Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial.
Hellström A; Nilsson AK; Wackernagel D; Pivodic A; Vanpee M; Sjöbom U; Hellgren G; Hallberg B; Domellöf M; Klevebro S; Hellström W; Andersson M; Lund AM; Löfqvist C; Elfvin A; Sävman K; Hansen-Pupp I; Hård AL; Smith LEH; Ley D
JAMA Pediatr; 2021 Apr; 175(4):359-367. PubMed ID: 33523106
[TBL] [Abstract][Full Text] [Related]
8. Daily Enteral DHA Supplementation Alleviates Deficiency in Premature Infants.
Baack ML; Puumala SE; Messier SE; Pritchett DK; Harris WS
Lipids; 2016 Apr; 51(4):423-33. PubMed ID: 26846324
[TBL] [Abstract][Full Text] [Related]
9. Choline intake influences phosphatidylcholine DHA enrichment in nonpregnant women but not in pregnant women in the third trimester.
West AA; Yan J; Jiang X; Perry CA; Innis SM; Caudill MA
Am J Clin Nutr; 2013 Apr; 97(4):718-27. PubMed ID: 23446897
[TBL] [Abstract][Full Text] [Related]
10. Randomized Controlled Trial of Early Docosahexaenoic Acid and Arachidonic Acid Enteral Supplementation in Very Low Birth Weight Infants.
Frost BL; Patel AL; Robinson DT; Berseth CL; Cooper T; Caplan M
J Pediatr; 2021 May; 232():23-30.e1. PubMed ID: 33358843
[TBL] [Abstract][Full Text] [Related]
11. Transport of long-chain polyunsaturated fatty acids in preterm infant plasma is dominated by phosphatidylcholine.
Bernhard W; Maas C; Shunova A; Mathes M; Böckmann K; Bleeker C; Vek J; Poets CF; Schleicher E; Franz AR
Eur J Nutr; 2018 Sep; 57(6):2105-2112. PubMed ID: 28638995
[TBL] [Abstract][Full Text] [Related]
12. Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.
Keim SA; Boone KM; Klebanoff MA; Turner AN; Rausch J; Nelin MA; Rogers LK; Yeates KO; Nelin L; Sheppard KW
JAMA Pediatr; 2018 Dec; 172(12):1126-1134. PubMed ID: 30357263
[TBL] [Abstract][Full Text] [Related]
13. Developmental changes in polyunsaturated fetal plasma phospholipids and feto-maternal plasma phospholipid ratios and their association with bronchopulmonary dysplasia.
Bernhard W; Raith M; Koch V; Maas C; Abele H; Poets CF; Franz AR
Eur J Nutr; 2016 Oct; 55(7):2265-74. PubMed ID: 26363610
[TBL] [Abstract][Full Text] [Related]
14. Effect of different levels of docosahexaenoic acid supply on fatty acid status and linoleic and α-linolenic acid conversion in preterm infants.
Sauerwald UC; Fink MM; Demmelmair H; Schoenaich PV; Rauh-Pfeiffer AA; Koletzko B
J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):353-63. PubMed ID: 22008957
[TBL] [Abstract][Full Text] [Related]
15. Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid: A secondary analysis of the Mega Donna Mega trial.
Sjöbom U; Andersson MX; Pivodic A; Lund AM; Vanpee M; Hansen-Pupp I; Ley D; Wackernagel D; Sävman K; Smith LEH; Löfqvist C; Hellström A; Nilsson AK
Clin Nutr; 2023 Jun; 42(6):962-971. PubMed ID: 37120902
[TBL] [Abstract][Full Text] [Related]
16. Enteral and parenteral lipid requirements of preterm infants.
Lapillonne A
World Rev Nutr Diet; 2014; 110():82-98. PubMed ID: 24751623
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy alters choline dynamics: results of a randomized trial using stable isotope methodology in pregnant and nonpregnant women.
Yan J; Jiang X; West AA; Perry CA; Malysheva OV; Brenna JT; Stabler SP; Allen RH; Gregory JF; Caudill MA
Am J Clin Nutr; 2013 Dec; 98(6):1459-67. PubMed ID: 24132975
[TBL] [Abstract][Full Text] [Related]
18. Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial.
Gould JF; Colombo J; Collins CT; Makrides M; Hewawasam E; Smithers LG
BMJ Open; 2018 May; 8(5):e020043. PubMed ID: 29804059
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid in plasma phosphatidylcholine may be a potential marker for in vivo phosphatidylethanolamine N-methyltransferase activity in humans.
da Costa KA; Sanders LM; Fischer LM; Zeisel SH
Am J Clin Nutr; 2011 May; 93(5):968-74. PubMed ID: 21411618
[TBL] [Abstract][Full Text] [Related]
20. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
